|
1007
|
Infanrix/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1008
|
Infanrix-IPV
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1014
|
Pediarix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1015
|
Kinrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1017
|
Decavac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1019
|
DT Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1021
|
Hexaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pateur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1022
|
Shan-5
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1025
|
EasyFive-TT
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1026
|
Pentaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd.
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1027
|
Pediacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1028
|
Tripacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1029
|
Tetravac or Tetravac Acellulaire
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1030
|
Boostrix Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1031
|
Td-pur
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1032
|
REPEVAX
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1033
|
Adacel Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1035
|
Td Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1041
|
Infanrix/Hib
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1042
|
Infanrix-IPV
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1048
|
Pediarix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1049
|
Kinrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1051
|
Hexaxim
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pateur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1052
|
Shan-5
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1055
|
EasyFive-TT
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1056
|
Pentaxim
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1057
|
Pediacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1058
|
Tripacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1059
|
Tetravac or Tetravac Acellulaire
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1060
|
Boostrix Polio
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1061
|
REPEVAX
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1062
|
Adacel Polio
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1067
|
Infanrix/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1068
|
Infanrix-IPV
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1074
|
Pediarix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1075
|
Kinrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1077
|
Decavac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1080
|
DT Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1081
|
Pentaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1083
|
Hexaxim
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1084
|
Shan-5
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1087
|
EasyFive-TT
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1088
|
Pediacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1089
|
Tripacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1090
|
Tetravac or Tetravac Acellulaire
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1091
|
Boostrix Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1092
|
Td-pur
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1093
|
REPEVAX
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1094
|
Adacel Polio
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1096
|
Td Polio Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1122
|
ViVaxim
|
Typhoid
|
Salmonella typhi
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1155
|
Comvax
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1159
|
Infanrix/Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1162
|
Hexaxim
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1163
|
Shan-5
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1165
|
EasyFive-TT
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1166
|
Pentaxim
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1167
|
Pediacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1244
|
BK1310
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT03891758
|
|
1245
|
Zilbrix-Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18352853
|
NCT00473668
|
|
1246
|
Tritanrix-HepB/ Hiberix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1247
|
Tritanrix-HepB/Hib-MenAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1248
|
GSK2202083A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01171989
|
|
1249
|
HR5I
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00551629
|
|
1250
|
Ravexis
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1251
|
DT Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1252
|
Tritanrix-HepB/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1254
|
GSK323527A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1255
|
GSK217744
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01453998
|
|
1256
|
DTaP-IPVvero
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1257
|
DTaP-IPVmkc
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1258
|
GSK2036874A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01106092
|
|
1260
|
TETRAXIM
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01031303
|
|
1261
|
SHAN6
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1263
|
Infanrix+Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18251697
|
NCT01449812
|
|
1265
|
GC3111
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Green Cross Corporation
|
Clinical - Phase 2
|
Intramuscular
|
34641798
|
NCT04238975
|
|
1266
|
Squarekids
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
|
Clinical - Discontinued
|
Subcutaneous
|
NA
|
NCT02907216
|
|
1267
|
COVAXIS
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00304265
|
|
1268
|
BK1301
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1270
|
diTekiBooster
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1271
|
SP306 (in Japan)
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1272
|
HEXAVAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1273
|
Tetrabik
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01926015
|
|
1274
|
Td-Rix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|
|
1275
|
COVAXIS
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00304265
|
|
1276
|
diTekiBooster
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1277
|
Squarekids
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
|
Clinical - Discontinued
|
Subcutaneous
|
NA
|
NCT02907216
|
|
1278
|
TETRAXIM
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01437423
|
|
1280
|
Tritanrix HB+Hib
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Crucell Holland BV
|
Clinical - Phase 4
|
NA
|
NA
|
NCT01357720
|
|
1281
|
HEXAVAC
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1282
|
SP306 (in Japan)
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1283
|
BK1301
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1285
|
DTaP-IPVvero
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1286
|
DTaP-IPVmkc
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1287
|
Tritanrix-HepB/Hib-MenAC
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1289
|
GSK323527A
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1290
|
SHAN6
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1291
|
BK1310
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT03891758
|
|
1292
|
Tetrabik
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01926015
|
|
1293
|
Tritanrix-HepB/ Hiberix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1294
|
diTekiBooster
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1295
|
COVAXIS
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1296
|
Squarekids
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
|
Clinical - Discontinued
|
Subcutaneous
|
NA
|
NCT02907216
|
|
1297
|
TETRAXIM
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01437423
|
|
1298
|
Tetrabik
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01926015
|
|
1300
|
REVAXIS
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1301
|
HEXAVAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1302
|
Td-Rix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|
|
1304
|
SP306 (in Japan)
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1305
|
BK1301
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1306
|
Tritanrix-HepB/Hib-MenAC
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1307
|
Tritanrix-HepB/Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1309
|
SP0204
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02274285
|
|
1310
|
DD 687 or DF 098
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02274285
|
|
1311
|
DTaP-IPVvero
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1312
|
DTaP-IPVmkc
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1313
|
Tritanrix-HepB/ Hiberix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1314
|
GSK323527A
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1316
|
BK1310
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT03891758
|
|
1317
|
SHAN6
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1351
|
Zilbrix-Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18352853
|
NCT00473668
|
|
1352
|
Tritanrix-HepB/ Hiberix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1353
|
Tritanrix-HepB/Hib-MenAC
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1354
|
GSK2202083A
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01171989
|
|
1355
|
HR5I
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00551629
|
|
1356
|
Tritanrix-HepB/Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1357
|
GSK323527A
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1358
|
SHAN6
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1359
|
Infanrix+Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18251697
|
NCT01449812
|
|
1360
|
HEXAVAC
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1363
|
CombAct-HIB
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
31444785
|
NCT00362336
|